Pediatrix Medical Group, Inc. (MD) stock
MDNYSEServices-HospitalsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 10/303% above fair value
$31.13−0.76 (-2.38%)
Close on Nov 17, 2026Market cap $2.43BP/E 16.9Yield –
Pediatrix Medical revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Pediatrix Medical's revenue for the twelve months ending Sep 30, 2026 was $1.96B, up 1.9% year over year. For fiscal 2025 it was $1.91B, down 4.9% from the year before. The highest annual figure on record is $3.25B in fiscal 2017.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.91B | -4.9% |
| FY2024 | Dec 31, 2024 | $2.01B | +0.9% |
| FY2023 | Dec 31, 2023 | $1.99B | +1.1% |
| FY2022 | Dec 31, 2022 | $1.97B | +3.2% |
| FY2021 | Dec 31, 2021 | $1.91B | +10.2% |
| FY2020 | Dec 31, 2020 | $1.73B | -2.6% |
| FY2019 | Dec 31, 2019 | $1.78B | +3.3% |
| FY2018 | Dec 31, 2018 | $1.72B | -47.0% |
| FY2017 | Dec 31, 2017 | $3.25B | +2.2% |
| FY2016 | Dec 31, 2016 | $3.18B | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $501.37M | +1.7% |
| Q2 FY2026 | Jun 30, 2026 | $487.78M | +4.0% |
| Q1 FY2026 | Mar 31, 2026 | $476.20M | +3.9% |
| Q4 FY2025 | Dec 31, 2025 | $493.77M | -1.7% |
| Q3 FY2025 | Sep 30, 2025 | $492.88M | -3.6% |
| Q2 FY2025 | Jun 30, 2025 | $468.84M | -7.0% |
| Q1 FY2025 | Mar 31, 2025 | $458.36M | -7.4% |
| Q4 FY2024 | Dec 31, 2024 | $502.36M | +1.2% |
| Q3 FY2024 | Sep 30, 2024 | $511.16M | +0.9% |
| Q2 FY2024 | Jun 30, 2024 | $504.30M | +0.7% |
| Q1 FY2024 | Mar 31, 2024 | $495.10M | +0.8% |
| Q4 FY2023 | Dec 31, 2023 | $496.44M | -3.4% |
| Q3 FY2023 | Sep 30, 2023 | $506.61M | +3.4% |
| Q2 FY2023 | Jun 30, 2023 | $500.58M | +3.0% |
| Q1 FY2023 | Mar 31, 2023 | $491.01M | +1.8% |
| Q4 FY2022 | Dec 31, 2022 | $513.84M | +3.1% |
| Q3 FY2022 | Sep 30, 2022 | $489.92M | -0.6% |
| Q2 FY2022 | Jun 30, 2022 | $486.03M | +2.8% |
| Q1 FY2022 | Mar 31, 2022 | $482.23M | +7.9% |
| Q4 FY2021 | Dec 31, 2021 | $498.53M | +19.7% |
| Q3 FY2021 | Sep 30, 2021 | $492.95M | +7.0% |
| Q2 FY2021 | Jun 30, 2021 | $472.96M | +13.8% |
| Q1 FY2021 | Mar 31, 2021 | $446.75M | +1.2% |
| Q4 FY2020 | Dec 31, 2020 | $416.63M | -9.2% |
| Q3 FY2020 | Sep 30, 2020 | $460.64M | +1.3% |
| Q2 FY2020 | Jun 30, 2020 | $415.44M | -5.4% |
| Q1 FY2020 | Mar 31, 2020 | $441.25M | +3.3% |
| Q4 FY2019 | Dec 31, 2019 | $458.60M | -48.4% |
| Q3 FY2019 | Sep 30, 2019 | $454.91M | -46.4% |
| Q2 FY2019 | Jun 30, 2019 | $439.15M | -49.2% |
| Q1 FY2019 | Mar 31, 2019 | $427.09M | -49.9% |
| Q4 FY2018 | Dec 31, 2018 | $888.44M | -2.5% |
| Q3 FY2018 | Sep 30, 2018 | $848.76M | -2.3% |
| Q2 FY2018 | Jun 30, 2018 | $864.99M | +2.6% |
| Q1 FY2018 | Mar 31, 2018 | $852.63M | +2.0% |
| Q4 FY2017 | Dec 31, 2017 | $910.82M | – |
| Q3 FY2017 | Sep 30, 2017 | $868.95M | – |
| Q2 FY2017 | Jun 30, 2017 | $842.94M | – |
| Q1 FY2017 | Mar 31, 2017 | $835.60M | – |
See a number that looks wrong?